We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about retinoblastoma, a rare eye cancer in children. Discover its causes, symptoms like white pupil and crossed eyes, diagnosis, and treatment options including chemotherapy and eye removal. High survival rates with early detection.
Retinoblastoma is a rare but serious form of eye cancer that primarily affects young children, typically those under the age of 5. It originates in the retina, the light-sensitive tissue at the back of the eye responsible for capturing light and sending visual information to the brain. While rare, early detection and prompt treatment are crucial for a positive outcome, with a high survival rate if caught in its early stages. This article aims to provide comprehensive information about retinoblastoma, tailored for parents in India, covering its causes, symptoms, diagnosis, treatment options, and preventive measures.
The retina is composed of specialized nerve cells called retinoblasts during fetal development. These cells mature into the nerve cells that form the retina. In retinoblastoma, these retinoblasts undergo genetic mutations, causing them to grow and divide uncontrollably, forming a tumor. This uncontrolled growth can occur in one or both eyes.
Retinoblastoma is broadly classified into two types:
The exact trigger for the genetic mutations that lead to retinoblastoma is not fully understood. However, the underlying cause is a change (mutation) in specific genes, primarily the RB1 gene, which normally helps control cell growth. When this gene is faulty, cells can grow uncontrollably, leading to tumor formation.
Key points regarding causes:
Recognizing the signs of retinoblastoma is critical for early diagnosis. Symptoms can sometimes be subtle, especially in very young infants. Parents and caregivers should be vigilant for the following:
It is important to note that these symptoms can also be caused by other, less serious eye conditions. However, any persistent or concerning eye changes in a child should be evaluated by a doctor.
If retinoblastoma is suspected, a comprehensive eye examination by an ophthalmologist, preferably one specializing in pediatric eye conditions, is essential. The diagnostic process may include:
The treatment for retinoblastoma depends on several factors, including the size and location of the tumor, whether it affects one or both eyes, and whether the cancer has spread. The primary goals of treatment are to cure the cancer, preserve vision if possible, and prevent metastasis.
The treatment plan is highly individualized and determined by a multidisciplinary team of specialists.
The prognosis for retinoblastoma is generally very good, especially with early detection. More than 90% of children diagnosed with retinoblastoma are cured. The 5-year survival rate is around 96%, meaning that the vast majority of children live long, healthy lives after treatment. The chances of long-term survival are significantly better if the cancer is confined to the eye and has not spread to other parts of the body.
Since retinoblastoma is primarily caused by genetic mutations, it cannot be prevented in the traditional sense. There are no lifestyle changes or environmental factors that parents can control to prevent its occurrence. However, for families with a history of retinoblastoma, early and regular screening of children can lead to timely diagnosis and treatment, which is the best form of
Overall, early action and medically verified advice remain the safest approach.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026